4 Areas where a CDMO can help your Viral Vector project. 10.7.2020 The therapeutic possibilities of cell and gene therapy are very appealing. The possibility to use a Viral Vector to carry the therapeutic gene into the target cells or to initiate cell transduction holds the potential …
Biovian – in the freshly released European Biotechnology Spring issue 2020 16.4.2020 European Biotechnology has published their spring issue with a bioprocessing special. Biovian is one of the CDMOs presented with an editorial article.
Biovian’s new facility for Viral Vector GMP manufacturing is completed 31.3.2020 Biovian has expanded its GMP Viral Vector contract development and manufacturing facilities.
